Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis

Trial Profile

Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Aug 2017

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Bronchiolitis
  • Focus Therapeutic Use
  • Acronyms NO-BRO
  • Sponsors AIT
  • Most Recent Events

    • 07 Aug 2017 According to an AIT Therapeutics Inc. media release, data from this trial is expected in the first half of 2018.
    • 13 Mar 2017 Status changed from not yet recruiting to recruiting.
    • 17 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top